PSA Screening Benefits Still Unclear After Two Studies Reveal Interim Data

Experts are still debating the value of prostate cancer screening after reviewing interim data from two ongoing studies published in the March 26 New England Journal of Medicine

More from Archive

More from Medtech Insight